Target audience: Translational and clinical researchers, students in biomedicine, Cancer IO partners.
Time: 12 January and 19 January 2022 at 15-18.
Place: Zoom (remote connection). Due to the current omicron situation, the training is organized fully online.
Registration: Please register via this link.
Have a look at the training programme below:
Cancer IO’s new report Cancer Immunotherapies in Finland was published in Helsinki University Think Corner on 9 March 2022. The objective of the report is to provide understanding of the current state of the adoption and
Welcome to watch the recording of the Cancer IO Sebinar “Single-cell tumor immunity”.
The report, published on 16 September 2021, describes the hospital preparedness for cancer clinical trials in Finland.
Welcome to watch a recording of our second Sebinar! This time we hear about the latest developments in the “next-gen” immunotherapies (post-immune checkpoint blockade) in the form of new therapies targeting the innate immune system.
cancerio-office@helsinki.fi